Archiv
Baxter Presents Preclinical Data at ISTH on its Investigational Compound BAX 499 for Potential Subcutaneous Hemophilia Therapy and Final Phase I Data on Recombinant Von Willebrand Factor
www.baxter.com/press_room/press_releases/2011/07_26_11_isth.html[more]
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at ISTH
Expert says he is convinced CFS is not caused by XMRV
While virus expert John M. Coffin thinks chronic fatigue syndrome is a physical disease and not a psychiatric one, he also said in this interview with the Boston Globe that based on his study, he does not think that the XMRV...[more]
Research center awarded $20M NIH grant for HIV drug development
The NIH has awarded a five-year grant worth $20 million to researchers at the Fred Hutchinson Cancer Research Center in Seattle to develop a treatment for HIV. Scientists at the research center are testing an approach in which...[more]
Study aims to detect presence of babesiosis in donated blood
The North Central region of the American Red Cross is part of a study to determine the presence of babesiosis, a tick-borne disease, in donated blood. The study, started in April by Dr. Dave Mair in partnership with the Holland...[more]
Trial will combine hepatitis C drugs from Tibotec and Pharmasset
A clinical study will assess the combination of Pharmasset's nucleotide polymerase inhibitor PSI-7977 and Tibotec's protease inhibitor TMC435 among hepatitis C patients. Xconomy [more]